Published in Liver on December 01, 1992
Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Proc Natl Acad Sci U S A (2000) 1.32
An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J Cell Biol (1996) 1.21
Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease. Am J Pathol (2006) 1.09
Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest (1996) 0.98
Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly-->Arg mutation. Am J Pathol (2000) 0.91
Hepatic fibrinogen storage disease due to the fibrinogen γ375 Arg → Trp mutation "fibrinogen Aguadilla" is present in Arabs. Saudi J Gastroenterol (2014) 0.78
Misfolding of Mutated Vasopressin Causes ER-Retention and Activation of ER-Stress Markers in Neuro-2a Cells. Open Neuroendocrinol J (2011) 0.78
Pancreatic cancer and fibrinogen storage disease. J Clin Pathol (1998) 0.75
Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy. BMC Gastroenterol (2005) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet (1990) 8.56
A classification of chronic hepatitis. Lancet (1968) 6.07
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A (1992) 4.47
Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology (1991) 4.47
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science (1999) 3.85
Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 3.63
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat (2007) 2.87
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81
T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology (1993) 2.39
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology (1982) 2.38
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology (1976) 2.17
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med (1993) 1.90
Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr (1993) 1.89
Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem (1995) 1.88
Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg (1999) 1.87
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology (1986) 1.75
Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology (1993) 1.75
Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63
9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet (1994) 1.63
The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology (1988) 1.59
Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci U S A (1992) 1.56
Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol (1998) 1.52
Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51
The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. Hepatology (1981) 1.47
IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? Eur J Gastroenterol Hepatol (1997) 1.47
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol (1988) 1.46
Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer (1996) 1.45
Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue. J Immunol Methods (1975) 1.44
Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol (1998) 1.44
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol (1976) 1.41
Molecular analysis of V(H)I+ B lymphocytes in hepatitis C patients. Dig Liver Dis (2003) 1.40
Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology (1990) 1.40
Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer. Bone Marrow Transplant (2004) 1.37
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol (1997) 1.35
Properties of delta-associated ribonucleic acid. Prog Clin Biol Res (1983) 1.34
Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst (1975) 1.33
Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet (1976) 1.31
Collagenous colitis: an abnormal collagen table? Two new cases and review of the literature. Am J Gastroenterol (1982) 1.30
Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol (1990) 1.27
In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology (1986) 1.24
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol (1990) 1.24
Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. Gut (1976) 1.23
Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology (1989) 1.23
Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol (1988) 1.23
A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology (1989) 1.23
Intrahepatic bile ducts under the lens. J Hepatol (1985) 1.22
Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization. Hepatology (1989) 1.22
Experimental transmission of the delta agent to chimpanzees. Prog Clin Biol Res (1983) 1.21
Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol (1987) 1.21
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica (1982) 1.16
Sequence variation in hepatitis C viral isolates. J Hepatol (1991) 1.15
Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma. Br J Cancer (1980) 1.14
Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology (1992) 1.09
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology (1992) 1.08
Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol (1991) 1.07
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. J Clin Pathol (1976) 1.05
Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol (1993) 1.05
Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes. Am J Pathol (1985) 1.05
Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology (1991) 1.04
Expression of MHC products by normal and abnormal bile duct epithelium. J Hepatol (1986) 1.04
Granulomatous gastritis: a morphological and diagnostic approach. Histopathology (1993) 1.03
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol (1997) 1.02
Role of hepatitis delta virus infection in hepatocellular carcinoma. Dig Dis Sci (1991) 1.02
Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology (1991) 1.02
Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol (1990) 1.01
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol (1986) 1.00
alpha-1-Antitrypsin immunoreactivity in islet cells of adult human pancreas. Cell Tissue Res (1977) 1.00
Metanephric adenoma. Histol Histopathol (1992) 1.00
Precancerous lesions of the biliary tree. J Surg Oncol Suppl (1993) 1.00
Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer (1992) 0.99
Parathyroid hormone-related peptide expression in primary and metastatic liver tumours. Histopathology (1993) 0.99
Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology (1987) 0.99
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology (1991) 0.98
Langerhans cells in various benign and malignant pigment-cell lesions of the skin. Arch Dermatol Res (1984) 0.98
Morphologic changes of the junctional complex of the hepatocytes in rat liver after bile duct ligation. Br J Exp Pathol (1978) 0.98
Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Gastroenterology (1983) 0.98
Colon cancer seeding after percutaneous fine needle aspiration of liver metastasis. J Hepatol (1993) 0.97
Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol (1999) 0.97
Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology (1990) 0.97
Serological markers of HBV infectivity. Ann Ist Super Sanita (1987) 0.96
Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection. Infect Immun (1983) 0.96
Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis. Hepatology (1983) 0.95
Proteins of hepatitis delta virus. Prog Clin Biol Res (1987) 0.95
Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study. Clin Exp Immunol (1990) 0.95
HLA expression in human hepatocellular carcinoma. Br J Cancer (1988) 0.95
Cellular composition of hypersensitivity-type granulomas: immunohistochemical analysis of tuberculous and sarcoidal lymphadenitis. Hum Pathol (1984) 0.95
The marginal zone in the human reactive lymph node. Am J Clin Pathol (1986) 0.94
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study. Differentiation (1995) 0.94
Evaluation of a modified fluorescent technique for the detection of Australia antigen in liver tissue. J Immunol Methods (1974) 0.94
Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol (1993) 0.94